CLAIM YOUR EBOOK!
The blueprint for cell & gene therapy manufacturing
Packed with insights from industry leaders at Cellular Origins, Cell and Gene Therapy Catapult, Cytiva, Fresensius Kabi, Thermo Fisher Scientific, and ScaleReady, learn how automation and innovation can help you scale seamlessly from clinical to commercial production while reducing costs and risk.
Uncover insights into…
🟨 How to scale CGT manufacturing efficiently
🟨 Unlocking regulatory & process challenges
🟨 The role of automation & robotics in reducing CoGs
🟨 With industry leader expert insights
There are two different pathways to scale right now. One is larger, all-in-one, higher volume systems that are essentially
GMP manufacturing in a box, but the big challenges with those is a therapy developer would need to change their manufacturing process to fit that system.
The alternative approach is to integrate existing unit operations with automated robotic infrastructures. The major benefit of this is that you don’t necessarily have to modify
your manufacturing process; you’re essentially implementing robotic help for your existing manufacturing process.